orphenadrine/aspirin/caffeine / Generic mfg. - LARVOL DELTA

Evaluation of patients treated with orphenadrine-aspirin-caffeine combination tablets for the management of headaches (AHS 2025) - "The findings of this study suggest that OAC may be an effective treatment option for patients with headaches. Significant reductions in headache pain intensity, frequency, and duration were observed, alongside notable improvements in functional impact and quality of life. Orphenadrine's role as a centrally acting muscle relaxant may contribute to these effects by relieving pericranial muscle tension and modulating pain signaling."

Clinical • CNS Disorders • Migraine • Musculoskeletal Pain • Pain

Nonopioid drugs for pain. (PubMed, Med Lett Drugs Ther) - No abstract available

Journal • Immunology • Neuralgia • Osteoarthritis • Pain • Rheumatology

Orphengesic Forte - an old analgesic combination returns. (PubMed, Med Lett Drugs Ther) - No abstract available

Journal • Pain

Opioid-free Pain Med Orphengesic Forte by Galt Pharmaceuticals Approved by FDA (Businesswire) - "Galt Pharmaceuticals announced a new drug approval to offer a non-opioid, non-controlled, non-addictive alternative for healthcare providers to manage patients suffering from pain. On July 8, 2020 the U.S. Food and Drug Administration approved the company’s Supplemental Abbreviated New Drug Application for Orphengesic Forte, over two months ahead of the scheduled goal date....Orphengesic Forte is indicated for the relief of mild to moderate pain of acute musculoskeletal disorders, paired with rest, physical therapy and other measures."

ANDA • Lumbar Back Pain • Musculoskeletal Pain • Pain